Crossmark

Multi-omics based consensus subtypes, development of prognostic signature, and identification of INHBB as a potential therapeutic target in colorectal cancer

Crossref DOI link: https://doi.org/10.1007/s10142-025-01691-1

Published Online: 2025-09-26

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Xu

Xu, Yuanmin

Sun, Rui

Wang, Sheng

Wei, Xiang
License Information

Text and Data Mining valid from 2025-09-26

Version of Record valid from 2025-09-26
More Information

Article History

Received: 11 December 2024

Revised: 1 August 2025

Accepted: 4 August 2025

First Online: 26 September 2025

Declarations

:

: The authors declare no competing interests.

: Pathology slides of CRC and adjacent normal tissues were a tissue microarray consisting of paired CRC and corresponding adjacent normal tissues was purchased from Shanghai Outdo Biotech Co., Ltd. (Shanghai, China) (ID: HColA030pg07-2) and approved by the Ethics Committee of Shanghai Outdo Biotech Co., Ltd (approval No. ZJBB-FM-071). All patients have provided informed consent.

: Not applicable.

Document is current

Any future updates will be listed below